Hualien, Taiwan

Hui-I Yang

This inventor holds 1 USPTO granted patent. Top assignee: Buddhist Tzu Chi Medical Foundation. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hui-I Yang. Retrieved from https://idiyas.com/inventor/hui-i-yang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in ALS Treatment by Hui-I Yang

Introduction

Hui-I Yang is a notable inventor based in Hualien, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of amyotrophic lateral sclerosis (ALS). His innovative approach has the potential to improve the lives of patients suffering from this debilitating condition.

Latest Patents

Hui-I Yang holds a patent for a method aimed at the prevention or treatment of amyotrophic lateral sclerosis by administering gastrodin. This pharmaceutical composition includes gastrodin and is designed to reduce neuronal axon degeneration and neurofibromin accumulation. The composition has shown effectiveness in improving symptoms of ALS and extending the life of patients affected by this disease. He has 1 patent to his name.

Career Highlights

Hui-I Yang is affiliated with the Buddhist Tzu Chi Medical Foundation, where he continues to work on innovative medical solutions. His research focuses on developing effective treatments for neurodegenerative diseases, showcasing his commitment to advancing medical science.

Collaborations

Hui-I Yang has collaborated with notable colleagues, including Chia-Yu Chang and Shinn-Zong Lin. Their combined efforts contribute to the ongoing research and development of treatments for ALS and other neurological disorders.

Conclusion

Hui-I Yang's work in the field of ALS treatment exemplifies the impact of innovative research on patient care. His contributions are paving the way for new therapeutic options that could significantly enhance the quality of life for those affected by this challenging condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…